Pharmacists in Wichita, Kansas


475 Pharmacists found in Wichita
female pharmacist

Virginia Neuwirth Lytle, RPH, MBA


Pharmacist
3770 N Woodlawn Blvd, Wichita, KS 67220
316-686-1838     316-686-1312

female pharmacist

Dr. Vonda Jeanne Foster, PHARM.D


Pharmacist - Nutrition Support
1402 S. Ridge Rd, Wichita, KS 67209
316-945-7455     316-945-7457

female pharmacist

Wesleigh Ann Bishop, PHARMD


Pharmacist
1100 N Saint Francis St Ste 200, Pharmacy, Wichita, KS 67214
316-268-8127    



male pharmacist

Dr. William Richard Stoner, PHARMD


Pharmacist
800 N Carriage Pkwy, Wichita, KS 67208
316-858-5890    

male pharmacist

William Blake Coultis, PHARMD


Pharmacist
2622 W Central Ave, Ste 302, Wichita, KS 67203
316-265-3300     316-265-3304

male pharmacist

William Luzendu Munguya, PHARMD


Pharmacist
803 N Broadway Ave, Wichita, KS 67214
316-768-5450     316-768-5452

female pharmacist

Yun Man, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
5500 E Kellogg Dr, Wichita, KS 67218
316-685-2221    

female pharmacist

Yvonne Elias-moussa, PHARMACIST


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1100 N Saint Francis Ave Ste 130, Wichita, KS 67214
316-264-3505     316-264-0978

male pharmacist

Dr. Zachary Thomas Wellner, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
550 N Hillside St, Wichita, KS 67214
316-962-2380    

male pharmacist

Zachary Hill, PHARMD


Pharmacist
6110 W Kellogg, Wichita, KS 67209
316-712-3558    

female pharmacist

Zarin Khan


Pharmacist
10800 E 21st St N, T-1944, Wichita, KS 67206
316-636-4352    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.